NASDAQ:NKTR   Nektar Therapeutics
not a financial advice
Comment:
failed half way due to bad news and law suit
Trade closed manually
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.